|Articles|July 1, 2017
- BioPharm International-07-01-2017
- Volume 30
- Issue 7
BioPharm International, July 2017 Issue (PDF)
Click the title above to open the BioPharm International July 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Laboratory Data Integrity Benefits from Electronic Systemsover 8 years ago
Do You Listen to What Your Data are Telling You?over 8 years ago
Matching Tools to Biophysical Analysis Demandsover 8 years ago
Tale of Two Financial Trendsover 8 years ago
Inspections: The Value of the Opening Presentationover 8 years ago
Balancing Protocols for Leachablesover 8 years ago
Biosafety Concerns of Single-Use Componentsover 8 years ago
FDA Continues to Promote Quality Drug ProductionNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5
